Skip to main content
SpringerLink
Log in
Book cover

Therapie der Hautkrankheiten pp 537–547Cite as

Dermatomyositis

  • Chapter

  • 225 Accesses

Zusammenfassung

Die Dermatomyositis (DM) ist eine chronische, in Schüben verlaufende Systemerkrankung des Haut-und Muskelgewebes, vermutlich auf autoimmunologischer Grundlage; sie ist im Vergleich zum LE oder zur Sklerodermie ein seltenes Krankheitsbild. Zu unterscheiden sind eine adulte Form im 5. bis 7. Dezenium und eine juvenile Variante, die sich meist bereits vor dem 10. Lebensjahr manifestiert. Der Dermatomyositis nahestehend ist die Polymyositis (PM), die auch als DM ohne kutane Manifestationen angesehen werden kann. Krankheiten aus dem DM/PM-Formenkreis lassen sich demnach klinisch klassifizieren (Tabelle 22–1). Allerdings dient eine derartige Klassifikation eher dem Verständnis der klinischen Verläufe und des damit verbundenen therapeutischen Vorgehens als der Abgrenzung gesonderter nosologischer Entitäten.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   299.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   378.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Abdel Naser BM, Chun SC, Gollnick H, Orfanos CE (1993) Amyopathic dermatomyositis (dermatomyositis sine myositis) in a male patient and possible induction by UV light. Eur J Dermatol 3:367–370

    Google Scholar 

  • Basset-Sequin N, Roujeau J-C, Gherardi R (1990) Prognostic factors and predictive signs of malignancy in adult dermatomyositis. Arch Dermatol 126: 633–637

    Article  Google Scholar 

  • Bernard P, Bonnetblanc JM (1993) Dermatomyositis and malignancy. J Invest Dermatol 100:128–132

    Article  Google Scholar 

  • Bohan A, Peter JB, Bowman RL, Pearson CM (1977) A computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine 56: 255–286

    Article  PubMed  CAS  Google Scholar 

  • Callen J (1985) Dermatomyositis — an update 1985. Sem Dermatol 4:114–125

    Google Scholar 

  • Cox PH, Lawrence C, Langtry JAA, Ive A (1990) Dermatomyositis. Arch Dermatol 126: 61–65

    Article  PubMed  CAS  Google Scholar 

  • Euwer RL, Sontheimer RD (1991) Amyopathic dermatomyositis (dermatomyositis sine myositis). J Am Acad Dermatol 24:959–966

    Article  PubMed  CAS  Google Scholar 

  • Henriksson KG, Sandstedt P (1982) Polymyositis treatment and prognosis: a study of 107 patients. Acta Neurol Scand 65: 280–300

    Article  PubMed  CAS  Google Scholar 

  • Kovacs SO, Kovacs C (1998) Dermatomyositis. J Am Acad Dermatol 39: 899–920

    Article  PubMed  CAS  Google Scholar 

  • Lakhanpal S, Bunch TW, Ilstrup DM, Melton LJ (1986) Polymyositis-dermatomyositis and malignant lesions: does an association exist? Mayo Clin Proc 61: 645–653

    Article  PubMed  CAS  Google Scholar 

  • Love LA, Leff RL, Fraser DD et al. (1991) A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine 70:360–374

    Article  PubMed  CAS  Google Scholar 

  • Manchul LA, Jin A, Pritchard KI et al. (1985) The frequency of malignant neoplasms in patients with polymyositis-dermatomyositis. Arch Intern Med 145:1835–1839

    Article  PubMed  CAS  Google Scholar 

  • Rockerbie NR, Woo TY, Callen JP, Giustina T (1989) Cutaneous changes of dermatomyositis precede muscle weakness. J Am Acad Dermatol 20: 629–632

    Article  PubMed  CAS  Google Scholar 

  • Sigurgeirsson B (1992) Skin disease and malignancy: an epidemiological study. Acta Derm Venereol [Suppl] 178: 1–110

    CAS  Google Scholar 

  • Sigurgeirsson V, Lindelöf B, Edhag O, Allander E (1992) Risk of cancer in patients with dermatomyositis or polymyositis. N Engl J Med 326:363–367

    Article  PubMed  CAS  Google Scholar 

  • Stonecipher MR, Jorizzo JL, White WL et al. (1993) Cutaneous changes of dermatomyositis in patients with normal muscle enzymes. Dermatomyositis sine myositis? J Am Acad Dermatol 28: 951–956

    Article  PubMed  CAS  Google Scholar 

  • Trautmann Ch, Abdel Naser BM, Soehnchen R et al. (1995) Prämyopathische vs. amyopathische Dermatomyositis. Hautarzt 46:47–52

    Article  PubMed  CAS  Google Scholar 

  • Adams EM, Plotz PH (1995) The treatment of myositis. Rheum Dis Clin North Am 21:179–202

    PubMed  CAS  Google Scholar 

  • Bodemer C, Teillac D, Le Bourgeois M et al. (1990) Efficacy of intravenous immunoglobulins in sclerodermatomyositis. Br J Dermatol 123:545–546

    Article  PubMed  CAS  Google Scholar 

  • Bombardieri S, Hughes GRV, Neri R et al. (1989) Cyclophosphamid in severe polymyositis. Lancet I:1138–1139

    Article  Google Scholar 

  • Boyd AS, Neldner KH (1994) Therapeutic options in dermatomyositis/polymyositis. Int J Dermatol 33:240–250

    Article  PubMed  CAS  Google Scholar 

  • Bunch TW (1981) Prednisone and azathioprine for polymyositis: longterm-follow-up. Arthritis Rheum 24: 45–48

    Article  PubMed  CAS  Google Scholar 

  • Casato M, Bonomo L, Caccavo D, Giorgi A (1989) Clinical effects of cyclosporin in dermatomyositis. Clin Exp Dermatol 15:121–123

    Article  Google Scholar 

  • Cherin P (1997) Recognition and management of myositis. Drugs 54:39–49

    Article  PubMed  CAS  Google Scholar 

  • Cherin P, Herson S, Wechsler B (1991) Efficacy of intravenous gammaglobulin therapy in chronic refractory polymositis and dermatomyositis: an open study with 20 adult patients. Am J Med 91:162–168

    Article  PubMed  CAS  Google Scholar 

  • Dalakas MC, Illa I, Dambrosia JM et al. (1993) A controlled trial of high dose intravenous immune globulin infusions as treatment for dermatomyositis. N Engl J Med 329:1993–2000

    Article  PubMed  CAS  Google Scholar 

  • Dau PC (1981) Plasmapheresis in idiopathic inflammatory myopathy. Experience with 35 patients. Arch Neurol 38: 544–552

    Article  PubMed  CAS  Google Scholar 

  • Derancourt C, Humbert P, Agache P (1992) Immunglobulines polyvalentes intraveineuses: utilisation en dermatologie. Ann Dermatol Vénéréol 119:487–488

    PubMed  CAS  Google Scholar 

  • Herson S, Lok C, Ronjeau JC et al. (1989) Plasma exchange in dermatomyositis and polymyositis. Retrospective study of 38 patients of plasma exchange. Ann Med Intern Paris 1040:453–455

    Google Scholar 

  • Joffe MM, Love LA, Leff RL et al. (1993) Drug therapy of the idiopathic inflammatory myopathies: predictors of response to prednisone, azathioprine, and methotrexate and a comparison of their efficacy. Am J Med 94: 379–387

    Article  PubMed  CAS  Google Scholar 

  • Kasteler JS, Callen JP (1997) Low-dose methotrexate administered weekly is an effective corticosteroid-sparing agent for the treatment of the cutaneous manifestations of dermatomyositis. J Am Acad Dermatol 36: 67–71

    Article  PubMed  CAS  Google Scholar 

  • Lang BA, Laxer RM, Murphy G et al. (1991). Treatment of dermatomyositis with intravenous gammaglobulin. Am J Med 91:169–172

    Article  PubMed  CAS  Google Scholar 

  • MacPherson A, Berth CC, Graham BRA (1989) Carcinomaassociated dermatomyositits responding to plasmapheresis. Clin Exp Dermatol 14:304–305

    Article  PubMed  CAS  Google Scholar 

  • Maugars YM, Berthelot JMM, Abbas AA et al. (1996) Longterm prognosis of 69 patients with dermatomyositis or polymyositis. Clin Exp Rheumatol 14: 263–274

    PubMed  CAS  Google Scholar 

  • Metzger AL, Bohan A, Goldberg LS et al. (1974) Polymyositis and dermatomyositis: combined methotrexate and corticosteroid therapy. Ann Intern Med 81:182–189

    Article  PubMed  CAS  Google Scholar 

  • Miller F, Leitman SF, Cronin ME et al. (1992) Controlled trial of plasma exchange and leukapheresis in polymyositis and dermatomyositis. N Engl J Med 326:1380–1382

    Article  PubMed  CAS  Google Scholar 

  • Morgan SH, Bernstein RM, Coppen J et al. (1985) Total body irradiation and the course of polymyositis. Arthritis Rheum 28: 831–835

    Article  PubMed  CAS  Google Scholar 

  • Qushmaq KA, Chalmers A, Esdaile JM (2000) Cyclosporin A in the treatment of refractory adult polymyositis/dermatomyositis: population based experience in 6 patients and literature review. J Rheumatol 27: 2855–2859

    PubMed  CAS  Google Scholar 

  • Sinoway PA, Callen JP (1993) Chlorambucil: an effective corticosteroid-sparing agent for patients with recalcitrant dermatomyositis. Arthritis Rheum 36:319–324

    Article  PubMed  CAS  Google Scholar 

  • Susa Y, Ikeda S, Yamada H, Ogawa H (1993) Double filtration plasmapheresis for the treatment of dermatomyositis. Clinical trial of 3 cases. Eur J Dermatol 3:438–441

    Google Scholar 

  • Targoff JN (1993) Humoral immunity in polymyositis/dermatomyositis. J Invest Dermatol 100:116S–123S

    Article  Google Scholar 

  • Woo TY, Callen JP, Voorhees JJ et al. (1984) Cutaneous lesions of dermatomyositis are improved by hydroxychloroquine. J Am Acad Dermatol 10:592–600

    Article  PubMed  CAS  Google Scholar 

  • Al-Mayouf SM, Laxer RM, Schneider R, Silverman ED, Feldman BM (2000) Intravenous immunoglobulin therapy for juvenile dermatomyositis: efficacy and safety. J Rheumatol 27: 2498–2503

    PubMed  CAS  Google Scholar 

  • Anderson L, Liter FA (1981) Plasmapheresis via central catheter in dermatomyositis. A new method for selected pediatric patients. J Pediatr 98:200–241

    Google Scholar 

  • Collet E, Dalac S, Maerens B et al. (1994) Juvenile Dermatomyositis: treatment with intravenous gammaglobulin. Br J Dermatol 130: 231–234

    Article  PubMed  CAS  Google Scholar 

  • Heckmatt J, Hasson N, Saunders C et al. (1987) Cyclosporin in juvenile dermatomyositis. Lancet I:1063–1066

    Google Scholar 

  • Hiketa T, Matsumo Y, Ohashi M, Sasaki R (1992) Juvenile dermatomyositis: a statistical study on 114 patients with dermatomyositis. J Dermatol 19:470–476

    PubMed  CAS  Google Scholar 

  • Lang BA, Laxer RM, Murphy G et al. (1991) Treatment of dermatomyositis with intravenous gammaglobulin. Am J Med 91: 69–72

    Article  Google Scholar 

  • Norins AL (1989) Juvenile dermatomyositis. Med Clin North Am 73:1193–1209

    PubMed  CAS  Google Scholar 

  • Olson NY, Lindsley CB (1989) Adjunctive use of hydroxychloroquine in childhood dermatomyositis. J Rheumatol 16:1545–1547

    PubMed  CAS  Google Scholar 

  • Pachmann LM (1995) Juvenile dermatomyositis. Pediatr Clin North Am 42:1071–1098

    Google Scholar 

  • Sansome A, Dubowitz V (1995) Intravenous immunoglobulin in juvenile dermatomyositis: four-year review of nine cases. Arch Dis Child 72: 25–28

    Article  PubMed  CAS  Google Scholar 

  • Wang WJ, Lo WL, Wong CK (1988) Calcinosis cutis in juvenile dermatomyositis: remarkable response to aluminium hydroxide therapy. Arch Dermatol 124:1721–1722

    Article  PubMed  CAS  Google Scholar 

  • Bernstein RM, Morgan SH, Chapmann J et al. (1984) Anti-J0–1 antibody: a marker for myositis with interstitial lung disease. Br Med J 289:151–152

    Article  CAS  Google Scholar 

  • Love LA, Leff RL, Fraser DD et al. (1991) A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define homogenous patient groups. Medicine 70:360–374

    Article  PubMed  CAS  Google Scholar 

  • Mirande M (1991) Aminoacyl-tRNA synthetase family from prokaryotes and eukaryotes: structural domains and their implications. Prog Nucleic Acid Res Mol Biol 40: 95–142

    Article  PubMed  CAS  Google Scholar 

  • Yoshida S, Akizuki M, Mimori M et al. (1983) The precipitating antibody to an acid nuclear protein antigen, the J0–1, in connective tissue diseases. A marker for subset of polymyositis with interstitial pulmonary fibrosis. Arthritis Rheum 26: 604–611

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik und Poliklinik für Dermatologie, Universitätsklinikum Benjamin Franklin Freie Universität Berlin, Fabeckstr. 60-62, 14195, Berlin, Deutschland

    Prof. Dr. Prof. h. c. Constantin E. Orfanos

  2. Hautklinik und Poliklinik, Eberhard-Karls-Universität, Liebermeisterstr. 25, 72076, Tübingen, Deutschland

    Prof. Dr. Claus Garbe

Authors
  1. Prof. Dr. Prof. h. c. Constantin E. Orfanos
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Prof. Dr. Claus Garbe
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

U. Blume-Peytavi C. C. Geilen S. Goerdt H. Gollnick E. Haneke F.-M. Köhn B. Tebbe R. Treudler Ch. C. Zouboulis

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Orfanos, C.E., Garbe, C. (2002). Dermatomyositis. In: Blume-Peytavi, U., et al. Therapie der Hautkrankheiten. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-56219-8_22

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-56219-8_22

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-62541-1

  • Online ISBN: 978-3-642-56219-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation